{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:33:13Z","timestamp":1790839993701,"version":"4.1.0"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T00:00:00Z","timestamp":1562889600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.01503","type":"journal-article","created":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T10:37:11Z","timestamp":1562927831000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":51,"title":["Symptomatic Carotid Atherosclerotic Plaques Are Associated With Increased Infiltration of Natural Killer (NK) Cells and Higher Serum Levels of NK Activating Receptor Ligands"],"prefix":"10.3389","volume":"10","author":[{"given":"Irene","family":"Bonaccorsi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Spinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Cantoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Barill\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narayana","family":"Pipit\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"De Pasquale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Oliveri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Cavaliere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Carrega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Benedetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Ferlazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,7,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.atherosclerosis.2005.01.046","article-title":"Identification of natural killer cells in human atherosclerotic plaque","volume":"180","author":"Bobryshev","year":"2005","journal-title":"Atherosclerosis"},{"key":"B2","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1253\/jcj.61.965","article-title":"Perforin-secreting killer cell infiltration in the aortic tissue of patients with atherosclerotic aortic aneurysm","volume":"61","author":"Seko","year":"1997","journal-title":"Jpn Circ J"},{"key":"B3","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1385\/IR:21:2-3:167","article-title":"Participation of innate and acquired immunity in atherosclerosis","volume":"21","author":"Curtiss","year":"2000","journal-title":"Immunol Res"},{"key":"B4","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0065-2776(08)60664-1","article-title":"Biology of natural killer cells","volume":"47","author":"Trinchieri","year":"1989","journal-title":"Adv Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"3146","DOI":"10.1182\/blood.V97.10.3146","article-title":"Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset","volume":"97","author":"Cooper","year":"2001","journal-title":"Blood"},{"key":"B6","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.1002\/1521-4141(2001010)31:10<3121::AID-IMMU3121>3.0.CO;2-4","article-title":"CD56bright cells differ in their KIR repertoire and cytotoxic features from CD56dim NK cells","volume":"31","author":"Jacobs","year":"2001","journal-title":"Eur J Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/S1471-4906(01)02060-9","article-title":"The biology of human natural killer-cell subsets","volume":"22","author":"Cooper","year":"2001","journal-title":"Trends Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.4049\/jimmunol.172.3.1455","article-title":"The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic","volume":"172","author":"Ferlazzo","year":"2004","journal-title":"J Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.1182\/blood-2002-09-2876","article-title":"CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity","volume":"101","author":"Fehniger","year":"2003","journal-title":"Blood"},{"key":"B10","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/nri3065","article-title":"Organ-specific features of natural killer cells","volume":"11","author":"Shi","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"344","DOI":"10.3389\/fimmu.2012.00344","article-title":"Mapping of NKp46(+) cells in healthy human lymphoid and non-lymphoid tissues","volume":"3","author":"Tomasello","year":"2012","journal-title":"Front Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"6418","DOI":"10.4049\/jimmunol.173.10.6418","article-title":"CD56bright NK cells are enriched at inflammatory sites and can engage with monocytes in a reciprocal program of activation","volume":"173","author":"Dalbeth","year":"2004","journal-title":"J Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"347","DOI":"10.3389\/fimmu.2012.00347","article-title":"Natural killer cell distribution and trafficking in human tissues","volume":"3","author":"Carrega","year":"2012","journal-title":"Front Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/nri.2016.34","article-title":"Emerging insights into natural killer cells in human peripheral tissues","volume":"16","author":"Bjorkstrom","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.immuni.2017.10.008","article-title":"The broad spectrum of human natural killer cell diversity","volume":"47","author":"Freud","year":"2017","journal-title":"Immunity"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e002860","DOI":"10.1161\/JAHA.115.002860","article-title":"Systematic evaluation of the cellular innate immune response during the process of human atherosclerosis","volume":"5","author":"van Dijk","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"B17","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1161\/CIRCRESAHA.117.311743","article-title":"Genetic depletion or hyperresponsiveness of natural killer cells do not affect atherosclerosis development","volume":"122","author":"Nour-Eldine","year":"2018","journal-title":"Circ Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.imlet.2015.09.006","article-title":"Natural killer cells in the innate immunity network of atherosclerosis","volume":"168","author":"Bonaccorsi","year":"2015","journal-title":"Immunol Lett"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.1161\/CIRCULATIONAHA.111.034850","article-title":"Immune activation resulting from NKG2D\/ligand interaction promotes atherosclerosis","volume":"124","author":"Xia","year":"2011","journal-title":"Circulation"},{"key":"B20","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.yexmp.2014.07.002","article-title":"MICA\/B expression in macrophage foam cells infiltrating atherosclerotic plaques","volume":"97","author":"Ikeshita","year":"2014","journal-title":"Exp Mol Pathol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1182\/blood-2013-01-481705","article-title":"Induction of B7-H6, a ligand for the natural killer cell-activating receptor NKp30, in inflammatory conditions","volume":"122","author":"Matta","year":"2013","journal-title":"Blood"},{"key":"B22","doi-asserted-by":"publisher","first-page":"4611","DOI":"10.4049\/jimmunol.175.7.4611","article-title":"Role of NK cell-activating receptors and their ligands in the lysis of mononuclear phagocytes infected with an intracellular bacterium","volume":"175","author":"Vankayalapati","year":"2005","journal-title":"J Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1002\/eji.201344130","article-title":"TLR activation of tumor-associated macrophages from ovarian cancer patients triggers cytolytic activity of NK cells","volume":"44","author":"Bellora","year":"2014","journal-title":"Eur J Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ejvs.2017.06.021","article-title":"Editor's choice\u2013management of atherosclerotic carotid and vertebral artery disease: 2017 clinical practice guidelines of the European Society for Vascular Surgery (ESVS)","volume":"55","author":"Writing","year":"2017","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"B25","first-page":"652","article-title":"Ultrasonographic features of carotid plaque and the risk of subsequent neurologic deficits","volume":"104","author":"Sterpetti","year":"1988","journal-title":"Surgery."},{"key":"B26","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S1078-5884(05)80194-7","article-title":"European Carotid Plaque Study Group","volume":"10","year":"1995","journal-title":"Eur J Vasc Endovasc Surg."},{"key":"B27","first-page":"676","article-title":"Carotid artery atheroma: comparison of preoperative B-mode ultrasound appearance with carotid endarterectomy specimen pathology","volume":"29","author":"Gray-Weale","year":"1988","journal-title":"J Cardiovasc Surg (Torino)."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejvs.2008.11.006","article-title":"ESVS guidelines. Invasive treatment for carotid stenosis: indications, techniques","volume":"37","author":"Liapis","year":"2009","journal-title":"Eur J Vasc Endovasc Surg."},{"key":"B29","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1053\/ejvs.2001.1560","article-title":"Eversion vs conventional carotid endarterectomy: a systematic review","volume":"23","author":"Cao","year":"2002","journal-title":"Eur J Vasc Endovasc Surg."},{"key":"B30","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1182\/blood-2013-11-427781","article-title":"Human innate lymphoid cells","volume":"124","author":"Hazenberg","year":"2014","journal-title":"Blood."},{"key":"B31","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1182\/blood-2009-04-215491","article-title":"CD94 surface density identifies a functional intermediary between the CD56bright and CD56dim human NK-cell subsets","volume":"115","author":"Yu","year":"2009","journal-title":"Blood."},{"key":"B32","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1002\/cncr.23239","article-title":"Natural killer cells infiltrating human nonsmall-cell lung cancer are enriched in CD56 bright CD16(-) cells and display an impaired capability to kill tumor cells","volume":"112","author":"Carrega","year":"2008","journal-title":"Cancer."},{"key":"B33","doi-asserted-by":"publisher","first-page":"4947","DOI":"10.4049\/jimmunol.178.8.4947","article-title":"CD56brightCD16- killer Ig-like receptor- NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation","volume":"178","author":"Romagnani","year":"2007","journal-title":"J Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1084\/jem.20090681","article-title":"The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans","volume":"206","author":"Brandt","year":"2009","journal-title":"J Exp Med"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1161\/ATVBAHA.108.173898","article-title":"Metalloproteinase expression in monocytes and macrophages and its relationship to atherosclerotic plaque instability","volume":"28","author":"Newby","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.atherosclerosis.2013.11.040","article-title":"Associations of matrix metalloproteinase-9 and monocyte chemoattractant protein-1 concentrations with carotid atherosclerosis, based on measurements of plaque and intima-media thickness","volume":"232","author":"Tan","year":"2013","journal-title":"Atherosclerosis"},{"key":"B37","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3389\/fcell.2016.00097","article-title":"Glycosyl-phosphatidyl-inositol (GPI)-anchors and metalloproteases: their roles in the regulation of exosome composition and NKG2D-mediated immune recognition","volume":"4","author":"Lopez-Cobo","year":"2016","journal-title":"Front Cell Dev Biol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"3429","DOI":"10.1158\/0008-5472.CAN-13-3017","article-title":"Metalloprotease-mediated tumor cell shedding of B7-H6, the ligand of the natural killer cell-activating receptor NKp30","volume":"74","author":"Schlecker","year":"2014","journal-title":"Cancer Res"},{"key":"B39","doi-asserted-by":"publisher","first-page":"6368","DOI":"10.1158\/0008-5472.CAN-07-6768","article-title":"Tumor-associated MICA is shed by ADAM proteases","volume":"68","author":"Waldhauer","year":"2008","journal-title":"Cancer Res"},{"key":"B40","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1152\/physrev.00024.2005","article-title":"Cytokines in atherosclerosis: pathogenic and regulatory pathways","volume":"86","author":"Tedgui","year":"2006","journal-title":"Physiol Rev"},{"key":"B41","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1161\/hc0102.101362","article-title":"Impact of infectious burden on extent and long-term prognosis of atherosclerosis","volume":"105","author":"Espinola-Klein","year":"2002","journal-title":"Circulation."},{"key":"B42","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1161\/hc2601.091703","article-title":"Impact of viral and bacterial infectious burden on long-term prognosis in patients with coronary artery disease","volume":"104","author":"Rupprecht","year":"2001","journal-title":"Circulation"},{"key":"B43","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1097\/QAD.0b013e3280108704","article-title":"Increased carotid intima-media thickness in HIV patients is associated with increased cytomegalovirus-specific T-cell responses","volume":"20","author":"Hsue","year":"2006","journal-title":"AIDS"},{"key":"B44","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1161\/ATVBAHA.113.302163","article-title":"Expansion of the NKG2C+ natural killer-cell subset is associated with high-risk carotid atherosclerotic plaques in seropositive patients for human cytomegalovirus","volume":"33","author":"Martinez-Rodriguez","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"364710","DOI":"10.1155\/2015\/364710","article-title":"Decreased regulatory T cells in vulnerable atherosclerotic lesions: imbalance between pro- and anti-inflammatory cells in atherosclerosis","volume":"2015","author":"Rohm","year":"2015","journal-title":"Mediators Inflamm"},{"key":"B46","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1161\/01.ATV.0000255581.38523.7c","article-title":"Enhanced expression of the homeostatic chemokines CCL19 and CCL21 in clinical and experimental atherosclerosis: possible pathogenic role in plaque destabilization","volume":"27","author":"Damas","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1093\/cvr\/cvu036","article-title":"Increased levels of CCR7 ligands in carotid atherosclerosis: different effects in macrophages and smooth muscle cells","volume":"102","author":"Halvorsen","year":"2014","journal-title":"Cardiovasc Res"},{"key":"B48","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.4049\/jimmunol.1502570","article-title":"Human CD56bright NK cells: an update","volume":"196","author":"Michel","year":"2016","journal-title":"J Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01503\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T10:37:15Z","timestamp":1562927835000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01503\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,12]]},"references-count":48,"alternative-id":["10.3389\/fimmu.2019.01503"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.01503","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,12]]},"article-number":"1503"}}